The combination of HCQ (200 mg daily) and atorvastatin (10 mg daily) successfully lowered high sensitivity C-reactive protein (hs-CRP) among Indian patients with dyslipidaemia 44. Here, CRP is linked to inherited lipid metabolism disorder.